EP Wealth Advisors’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$238K Sell
4,938
-6,392
-56% -$298K ﹤0.01% 1305
2025
Q4
$549K Buy
+11,330
New +$562K ﹤0.01% 838
2025
Q2
$257K Buy
5,323
+540
+11% +$27.6K ﹤0.01% 1105
2025
Q1
$265K Sell
4,783
-1,096
-19% -$59.3K ﹤0.01% 976
2024
Q4
$284K Sell
5,879
-2,016
-26% -$103K ﹤0.01% 892
2024
Q3
$455K Buy
7,895
+2,548
+48% +$138K ﹤0.01% 719
2024
Q2
$259K Buy
5,347
+1,002
+23% +$48.3K ﹤0.01% 693
2024
Q1
$211K Sell
4,345
-690
-14% -$33.7K ﹤0.01% 721
2023
Q4
$250K Buy
5,035
+255
+5% +$12.5K ﹤0.01% 669
2023
Q3
$256K Buy
4,780
+563
+13% +$30K ﹤0.01% 594
2023
Q2
$328K Buy
+4,217
New +$227K ﹤0.01% 543
2022
Q3
Sell
-10,806
Closed -$541K 593
2022
Q2
$541K Buy
10,806
+3,478
+47% +$185K 0.01% 355
2022
Q1
$376K Buy
7,328
+329
+5% +$17K 0.01% 441
2021
Q4
$351K Buy
6,999
+948
+16% +$46.9K 0.01% 435
2021
Q3
$292K Sell
6,051
-716
-11% -$36.4K 0.01% 436
2021
Q2
$356K Buy
+6,767
New +$353K 0.01% 408

Other funds holding SNY

EP Wealth Advisors's SNY Position: Q1 2026 in Review

EP Wealth Advisors reduced its Sanofi (SNY) stake by 56% in Q1 2026, selling an estimated $298K and leaving 4,938 shares worth $238K. The position accounts for ﹤0.01% of the portfolio, ranked #1305.

EP Wealth Advisors first reported a position in SNY in Q2 2021 and has held it in 16 quarters since. The position peaked at $549K in Q4 2025. 737 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

  • EP Wealth Advisors held 4,938 shares of Sanofi worth $238K as of Q1 2026.
  • EP Wealth Advisors sold 6,392 Sanofi shares in Q1 2026, an estimated $298K.
  • Sanofi made up ﹤0.01% of EP Wealth Advisors's portfolio in Q1 2026, its #1305 holding.
  • EP Wealth Advisors first reported a position in Sanofi in Q2 2021 and has held it in 16 quarters since.
  • EP Wealth Advisors's Sanofi position peaked at $549K in Q4 2025.
  • 737 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on EP Wealth Advisors's 13F filing for Q1 2026, filed 14 May 2026.